Recent biosimilar and biologic developments included Health Canada approval of denosumab biosimilars, FDA review actions, and new licensing and commercialisation agreements. Other updates covered court, trial and reimbursement agenda decisions.
South Korean pharmaceutical companies are expanding digital healthcare businesses as they seek new revenue sources. The domestic market recorded 7.7409 trillion won in sales in 2024, while companies including Daewoong Pharmaceutical, Dong-A ST, Handok and Yuhan are advancing products and investments.
Tennessee has implemented comprehensive pharmacist scope-of-practice expansion allowing independent prescribing, testing, and treatment for select conditions. The legislation enables pharmacists to prescribe medications including antivirals, contraceptives, and naloxone without collaborative agreements. This expansion aims to improve healthcare access, particularly in rural areas with provider shortages.
Australia's National Health and Medical Research Council marks 90 years of funding medical breakthroughs while facing warnings that research institutes could exhaust capital within a decade. The NHMRC's success includes funding the HPV vaccine that put Australia on track to eliminate cervical cancer by 2035, but sustained funding is needed to maintain world-class research capabilities.
Prognica Labs and NextGen Immuno Therapeutics announced a strategic partnership to advance AI-powered immune diagnostics and personalized medicine across the GCC, India, and the United States, targeting oncology, transplant medicine, and autoimmune disorders.
A 30-year study of nearly 200,000 adults found that diet quality matters more than macronutrient ratios for heart health, with both healthy low-carb and low-fat diets reducing coronary heart disease risk equally.
Health and Human Services Secretary Robert F. Kennedy Jr. announced plans to review the safety of ultra-processed foods, criticizing the GRAS exemption that allows companies to verify ingredient safety without FDA oversight since 1997.
The global stem cell therapy market is projected to grow from $18.13 billion in 2025 to $59.70 billion by 2035 at a 12.66% CAGR, driven by chronic disease prevalence and regenerative medicine advances.
The FDA will now require a single pivotal clinical trial as the default for novel medicine approvals, replacing its decades-old two-trial standard. The policy aims to reduce development costs and accelerate innovation.
The FDA has reversed its earlier refusal and will now review Moderna's mRNA-1010 seasonal influenza vaccine application, setting an August 5, 2026 review deadline after the company proposed a revised regulatory approach based on age groups.
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT07594418 |
Phenotype-Guided Weaning in Mechanically Ventilated Patients With Chronic Comorbidities |
NOT_YET_RECRUITING | NA |
| NCT07592962 |
Whole-life Investigation of Lishui Longevity |
RECRUITING | |
| NCT07589673 |
Development and Evaluation of an Online Shared Decision-Making Educational Program for Nurses and Patients With Chronic Diseases |
RECRUITING | NA |
| NCT07541547 |
Adult Disease Risk Prediction Using Wearables, Hearing, and Health Data |
RECRUITING | |
| NCT07536256 |
Community Connections Through Native Hawaiian Cultural Values to Strengthen Youth Resilience, Health, and Well-Being |
RECRUITING | NA |
| NCT07495891 |
Sustainability of the Effects of an Adapted Physical Activity Program on Physical Fitness and Psycho-behavioral Factors in Patients With Chronic Diseases |
NOT_YET_RECRUITING | NA |
| NCT07479810 |
Chronic Diseases in Primary Care |
ENROLLING_BY_INVITATION | NA |
| NCT07441655 |
Families Implementing Good Health Traditions for Life |
RECRUITING | NA |
| NCT07422922 |
Click & Pick Study |
RECRUITING | NA |
| NCT07391046 |
Integrating Vaccination Into Hospital Care Pathways for Vulnerable Patients |
NOT_YET_RECRUITING |
